Seligson ND - Search Results

1

Evaluation of the timing of MRSA PCR nasal screening: How long can a negative assay be used to rule out MRSA-positive respiratory cultures?

Turner SC, Seligson ND, Parag B, Shea KM, Hobbs ALV. Turner SC, et al. Among authors: seligson nd. Am J Health Syst Pharm. 2021 May 24;78(Supplement_2):S57-S61. doi: 10.1093/ajhp/zxab109. Am J Health Syst Pharm. 2021. PMID: 33788910

2

Evaluating the Impact of the Addition of Cladribine to Standard Acute Myeloid Leukemia Induction Therapy.

Seligson ND, Hobbs ALV, Leonard JM, Mills EL, Evans AG, Goorha S. Seligson ND, et al. Ann Pharmacother. 2018 May;52(5):439-445. doi: 10.1177/1060028017749214. Epub 2017 Dec 14. Ann Pharmacother. 2018. PMID: 29241342

3

Adding the second T: Elevating STAR to START for behavioral interviewing.

Apple JM, Guerci JC, Seligson ND, Curtis SD. Apple JM, et al. Among authors: seligson nd. Am J Health Syst Pharm. 2021 Jan 1;78(1):18-21. doi: 10.1093/ajhp/zxaa356. Am J Health Syst Pharm. 2021. PMID: 33155021 No abstract available.

4

Comparison of variants in TPMT and NUDT15 between sequencing and genotyping methods in a multistate pediatric institution.

Cook KJ, Grusauskas V, Gloe L, Duong BQ, Gresh RC, Kolb EA, Bansal M, Bechtel AS, Nagasubramanian R, Kirwin SM, Blake KV, Seligson ND. Cook KJ, et al. Among authors: seligson nd. Clin Transl Sci. 2023 Aug;16(8):1352-1358. doi: 10.1111/cts.13539. Epub 2023 Jul 6. Clin Transl Sci. 2023. PMID: 37415296 Free PMC article.

5

Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast Cancer.

Seligson JM, Patron AM, Berger MJ, Harvey RD, Seligson ND. Seligson JM, et al. Among authors: seligson nd. Ann Pharmacother. 2021 Jul;55(7):921-931. doi: 10.1177/1060028020966548. Epub 2020 Oct 17. Ann Pharmacother. 2021. PMID: 33070624 Review.

6

Development of a Campus-Wide Community Service Initiative during a Pandemic.

King K, Davis HE, Moorman-Li R, Cook KJ, Seligson ND. King K, et al. Among authors: seligson nd. Pharmacy (Basel). 2022 Apr 19;10(3):47. doi: 10.3390/pharmacy10030047. Pharmacy (Basel). 2022. PMID: 35645326 Free PMC article.

7

Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma.

Bill KLJ, Seligson ND, Hays JL, Awasthi A, Demoret B, Stets CW, Duggan MC, Bupathi M, Brock GN, Millis SZ, Shakya R, Timmers CD, Wakely PE Jr, Pollock RE, Chen JL. Bill KLJ, et al. Among authors: seligson nd. Oncologist. 2019 Jul;24(7):989-996. doi: 10.1634/theoncologist.2019-0047. Epub 2019 Apr 24. Oncologist. 2019. PMID: 31019022 Free PMC article.

8

BRCA1/2 Functional Loss Defines a Targetable Subset in Leiomyosarcoma.

Seligson ND, Kautto EA, Passen EN, Stets C, Toland AE, Millis SZ, Meyer CF, Hays JL, Chen JL. Seligson ND, et al. Oncologist. 2019 Jul;24(7):973-979. doi: 10.1634/theoncologist.2018-0448. Epub 2018 Dec 12. Oncologist. 2019. PMID: 30541756 Free PMC article.

9

Common Secondary Genomic Variants Associated With Advanced Epithelioid Hemangioendothelioma.

Seligson ND, Awasthi A, Millis SZ, Turpin BK, Meyer CF, Grand'Maison A, Liebner DA, Hays JL, Chen JL. Seligson ND, et al. JAMA Netw Open. 2019 Oct 2;2(10):e1912416. doi: 10.1001/jamanetworkopen.2019.12416. JAMA Netw Open. 2019. PMID: 31577358 Free PMC article.

10

Association of ANRIL Polymorphism With Overall Survival in Adult Patients With Hematologic Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation.

Li J, Seligson N, Zhang X, Johnson J, Vangundy Z, Wang D, Phelps M, Hofmeister C, Sadee W, Poi MJ. Li J, et al. Anticancer Res. 2020 Oct;40(10):5707-5713. doi: 10.21873/anticanres.14585. Anticancer Res. 2020. PMID: 32988896

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page